Bcl9 Depletion Modulates Endothelial Cell in Tumor Immune Microenvironment in Colorectal Cancer Tumor

por Wei, Zhuang, Feng, Mei, Wu, Zhongen, Shen, Shuru, Zhu, Di
Publicado 2021

Inhibition of BCL9 Modulates the Cellular Landscape of Tumor-Associated Macrophages in the Tumor Immune Microenvironment of Colorectal Cancer

por Wei, Zhuang, Yang, Mengxuan, Feng, Mei, Wu, Zhongen, Rosin-Arbesfeld, Rina, Dong, Jibin, Zhu, Di
Publicado 2021

Targeting Wnt Signaling in the Tumor Immune Microenvironment to Enhancing EpCAM CAR T-Cell therapy

por Li, Weizhen, Zhou, Yang, Wu, Zhongen, Shi, Yaoping, Tian, Enming, Zhu, Yingqi, Wang, Tao, Dou, Wei, Meng, Xiangjing, Chen, Ming, Zhai, Bo, Zhu, Di
Publicado 2021

RORγt agonist enhances anti-PD-1 therapy by promoting monocyte-derived dendritic cells through CXCL10 in cancers

por Xia, Li, Tian, Enming, Yu, Mingcheng, Liu, Chenglong, Shen, Lian, Huang, Yafei, Wu, Zhongen, Tian, Jinlong, Yu, Ker, Wang, Yonghui, Xie, Qiong, Zhu, Di
Publicado 2022

BCL9 regulates CD226 and CD96 checkpoints in CD8(+) T cells to improve PD-1 response in cancer

por Feng, Mei, Wu, Zhongen, Zhou, Yan, Wei, Zhuang, Tian, Enming, Mei, Shenglin, Zhu, Yuanyuan, Liu, Chenglong, He, Fenglian, Li, Huiyu, Xie, Cao, Jin, Joy, Dong, Jibin, Yang, Dehua, Yu, Ker, Qian, Junbin, Lambrechts, Diether, Wang, Ming-Wei, Zhu, Di
Publicado 2021